Indivior PLC today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses ...
Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...
FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...
Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the ...
US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...
Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence imaging capabilities. It is best suited for high-content screening (HCS) and ...
The WHO has labeled drug-resistant gonorrhea a serious and urgent public health threat. If left untreated, gonorrhea ...
MARIN COUNTY PUBLIC HEALTH officials are urging families and health care providers to maintain strong newborn vaccination practices following last week’s ...
Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and ...
MedPage Today on MSN
Third-Generation PCSK9 Inhibitor Approved for High Cholesterol
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results